» Articles » PMID: 222803

Assay of Human Interferon in Vero Cells by Several Methods

Overview
Specialty Microbiology
Date 1979 Apr 1
PMID 222803
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Four methods for the assay of human interferon in Vero cells were compared based on the inhibition of viral cytopathic effect (CPE) in tubes, the inhibition of CPE in microplates, the reduction of plaques, and the inhibition of quantitative hemadsorption. For inhibition of CPE, Sindbis virus, vesicular stomatitis virus, poliovirus type 2, and vaccinia virus were used for challenge. In the plaque reduction method, Sindbis virus, vesicular stomatitis virus, and poliovirus were employed, and Newcastle disease virus was used in the quantitative hemadsorption assay. Sindbis virus was most susceptible to interferon in those tests measuring inhibition of CPE, but vesicular stomatitis virus was as sensitive in the plaque reduction method. Highest titers of interferon were recorded in microplates, especially with Sindbis virus as the challenge agent, followed by the quantitative inhibition assay. The CPE inhibition method was the simplest, and the quantitative hemadsorption assay was the most rapid to perform. Reproducibilities, as shown by the coefficient of variation, were 15, 39, and 59% for plaque reduction, CPE inhibition in tubes, and CPE inhibition in microplates, respectively.

Citing Articles

Anti-Interferon Alpha Antibodies in Patients with High-Risk BCR/ABL-Negative Myeloproliferative Neoplasms Treated with Recombinant Human Interferon-α.

Aruna , Li L Med Sci Monit. 2018; 24:2302-2309.

PMID: 29693647 PMC: 5928850. DOI: 10.12659/MSM.907876.


Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy.

Dold C, Rodriguez Urbiola C, Wollmann G, Egerer L, Muik A, Bellmann L Mol Ther Oncolytics. 2016; 3:16021.

PMID: 27738655 PMC: 5040171. DOI: 10.1038/mto.2016.21.


Basal Activation of Type I Interferons (Alpha2 and Beta) and 2'5'OAS Genes: Insights into Differential Expression Profiles of Interferon System Components in Systemic Sclerosis.

de Oliveira D, Magno de Freitas Almeida G, Guedes A, Santos F, Bonjardim C, Peregrino Ferreira P Int J Rheumatol. 2011; 2011:275617.

PMID: 22121373 PMC: 3206376. DOI: 10.1155/2011/275617.


Alpha interferon and not gamma interferon inhibits salmonid alphavirus subtype 3 replication in vitro.

Xu C, Guo T, Mutoloki S, Haugland O, Marjara I, Evensen O J Virol. 2010; 84(17):8903-12.

PMID: 20573808 PMC: 2919011. DOI: 10.1128/JVI.00851-10.


Species-independent bioassay for sensitive quantification of antiviral type I interferons.

Kuri T, Habjan M, Penski N, Weber F Virol J. 2010; 7:50.

PMID: 20187932 PMC: 2846901. DOI: 10.1186/1743-422X-7-50.


References
1.
Finter N . QUANTITATIVE HAEMADSORPTION, A NEW ASSAY TECHNIQUE. I. ASSAY OF INTERFERON. Virology. 1964; 24:589-97. DOI: 10.1016/0042-6822(64)90212-0. View

2.
GRESSER I . Metamorphosis of human amnion cells induced by preparations of interferon. Proc Natl Acad Sci U S A. 1961; 47:1817-22. PMC: 223217. DOI: 10.1073/pnas.47.11.1817. View

3.
JAMESON P, Dixon M, Grossberg S . A sensitive interferon assay for many species of cells: encephalomyocarditis virus hemagglutinin yield reduction. Proc Soc Exp Biol Med. 1977; 155(2):173-8. DOI: 10.3181/00379727-155-39768. View

4.
Oie H, Buckler C, Uhlendorf C, Hill D, Baron S . Improved assays for a variety of interferons. 1. Proc Soc Exp Biol Med. 1972; 140(4):1178-81. DOI: 10.3181/00379727-140-36636. View

5.
Hallum J, Thacore H, Youngner J . Factors affecting the sensitivity of different viruses to interferon. J Virol. 1970; 6(2):156-62. PMC: 376102. DOI: 10.1128/JVI.6.2.156-162.1970. View